Filing Details

Accession Number:
0001104659-15-053992
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-28 21:52:40
Reporting Period:
2015-07-24
Filing Date:
2015-07-28
Accepted Time:
2015-07-28 21:52:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061027 Sunesis Pharmaceuticals Inc SNSS Pharmaceutical Preparations (2834) 943295878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197350 Eric Bjerkholt C/O Sunesis Pharmaceuticals, Inc.
395 Oyster Point Boulevard, Suite 400
South San Francisco CA 94080
Evp, Cfo & Corp. Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-07-24 11,105 $1.32 84,634 No 4 X Indirect See footnote
Common Stock Disposition 2015-07-24 4,239 $3.46 80,395 No 4 S Indirect See footnote
Common Stock Acquisiton 2015-07-24 5,551 $1.32 85,946 No 4 X Indirect See footnote
Common Stock Disposition 2015-07-24 2,119 $3.46 83,827 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Indirect See footnote
No 4 S Indirect See footnote
No 4 X Indirect See footnote
No 4 S Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Disposition 2015-07-24 11,105 $0.00 11,105 $1.32
Common Stock Warrant (right to buy) Disposition 2015-07-24 5,551 $0.00 5,551 $1.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-04-03 2016-04-03 No 4 X Indirect
0 2009-10-30 2016-10-30 No 4 X Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 49,913 Direct
Footnotes
  1. The shares are held by the Bjerkholt/Hahn Family Trust for which reporting person is the Trustee.
  2. On July 24, 2015, the reporting person exercised a warrant to purchase 11,105 shares of SNSS common stock for $1.32 a share. The reporting person paid the exercise price on a cashless basis, resulting in SNSS's withholding of 4,239 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 6,866 shares.
  3. On July 24, 2015, the reporting person exercised a warrant to purchase 5,551 shares of SNSS common stock for $1.32 a share. The reporting person paid the exercise price on a cashless basis, resulting in SNSS's withholding of 2,119 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 3,432 shares.